Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.
Uppal, Shelley K; Kearns, Donovan G; Chat, Vipawee S; Wu, Jashin J.
J Drugs Dermatol ; 20(7): 806, 2021 Jul 01.
Article in English | MEDLINE | ID: covidwho-1299843

Subject(s)
COVID-19/complications , Cytokine Release Syndrome/drug therapy , Cytokine Release Syndrome/etiology , Enzyme Inhibitors/therapeutic use , Janus Kinase 1/antagonists & inhibitors , Pyrimidines/therapeutic use , Respiratory Distress Syndrome/drug therapy , Respiratory Distress Syndrome/etiology , Sulfonamides/therapeutic use , Humans
2.
Dermatologists as social media contributors during the COVID-19 pandemic.
Uppal, Shelley K; Kearns, Donovan G; Chat, Vipawee S; Wu, Jashin J.
Cutis ; 106(5): 245-246, 2020 11.
Article in English | MEDLINE | ID: covidwho-1068029

Subject(s)
COVID-19/complications , Skin Diseases, Viral/epidemiology , Social Media/statistics & numerical data , Adolescent , Adult , COVID-19/epidemiology , Child , Dermatology/organization & administration , Humans , Young Adult
3.
Clinical management of psoriasis patients during the COVID-19 pandemic.
Chat, Vipawee S; Uppal, Shelley K; Kearns, Donovan G; Wu, Jashin J.
J Dermatolog Treat ; 33(2): 1166-1167, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-636257

ABSTRACT

Psoriasis is a systemic immune-mediated inflammatory disease that requires consistent treatment and follow-up. Given that COVID-19 will persist in the coming years, dermatologists need to adjust their practices accordingly to care for their patients, particularly psoriasis patients managed with systemic therapies. We provide guidelines for optimizing care for psoriasis patients, including considerations for medication management, lifestyle adjustments, and utilization of telemedicine.


Subject(s)
Biological Products , COVID-19 , Psoriasis , Telemedicine , Biological Products/therapeutic use , Humans , Pandemics , Psoriasis/drug therapy , Psoriasis/epidemiology , SARS-CoV-2
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL